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INTRODUCTION
Amyotrophic Lateral Sclerosis (ALS) is an adult-onset neurodegenerative disorder affecting both upper and lower motor neurons (MNs). Mutations in the gene coding for the antioxidant enzyme Cu, Zn-superoxide dismutase 1 (SOD1) occur in 10%-20% of familial ALS (FALS) cases and in up to 7% of sporadic ALS (SALS) cases (Andersen, 2006; Rosen, 1993) . More than 150 different mutations, mostly dominant inherited, have been identified in ALS patients. These findings enabled the subsequent development of novel experimental animal models: currently ALS research relies heavily on transgenic rodents expressing mutant human SOD1 (hSOD1). Accordingly, a MN disease phenotype results from the expression of gain-of-function of different hSOD1 mutants in rodents, rather than SOD1 gene targeting (Turner and Talbot, 2008) . These animal models contributed to the discovery of several pathogenetic mechanisms underlying the disease including axonal transport defects, oxidative stress, protein misfolding, mitochondrial dysfunction, excitotoxicity and altered RNA metabolism (Peviani et al., 2010) , nevertheless the molecular mechanisms responsible for the selective MN degeneration are not yet fully elucidated. The lack of translation from bench to bedside represents a major drawback against this animal model (Benatar, 2007; Perrin, 2014) . Several factors are supposed to be involved in the discrepancy between the results obtained in mouse models and patients including phylogenetic distance among species, size, lifespan and subtle differences of anatomical structures and physiology. Recent meta-analysis of drug trials in mice revealed that several studies were underpowered and most treatments were applied at pre-symptomatic stage, whereas treatments of ALS patients start only months or even years after the onset of the disease (Perrin, 2014) . Interestingly, it has been suggested that the onset of clinical symptoms is preceded by a long pre-symptomatic period in which there is a system dysfunction but not clinical manifestations due to an intrinsic reserve within the neuromuscular system or recruitment of compensatory mechanisms (Eisen, 2014; Talbot, 2014) . Understanding what happen during the long time elapsed between the onset of the pathological process triggered ACCEPTED MANUSCRIPT
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by the gene mutation and the onset of overt symptomatic disease has important implications as this phase is likely to be the best target for therapeutic trials. A critical issue is developing an ALS animal model which recapitulate the long preclinical/clinical phases as in patients, to allow the identification and validation of pre-symptomatic diagnostic biomarkers and biotargets for effective therapeutic interventions. In this respect, pigs which have a long lifespan and have been employed for modeling several human diseases including neurodegenerative disorders (Holm et al., 2016; Lind et al., 2007) may present advantages as compared to rodent models. As such, a hSOD1 G93A transgenic (Tg) swine was generated by somatic cell nuclear transfer (SCNT) of primary porcine adult male fibroblasts stably expressing the pathological allele of the human SOD1 gene carrying the glycine-to-alanine conversion at the 93rd codon (G93A) (Chieppa et al., 2014) .
Here, we showed that hSOD1 G93A Tg swine shares several features of ALS at the symptomatic phase. Moreover, the disease is transmissible to the progeny with mendelian traits. Contrary to the rodent models, these Tg pigs have a quite long pre-symptomatic phase of about 27 months of age, which is a relevant pathological feature in common with patients.
Furthermore, we investigated TDP-43, a major neuropathological hallmark of ALS (Neumann, 2009 ). In spinal cord of ALS patients, TDP-43 pathology is most commonly observed in sporadic cases, but it has also been detected in mutant-SOD1 familial cases and mouse models (Lauranzano et al., 2015; Marino et al., 2015; Sumi et al., 2009) . Increasing amounts of the total TDP-43, which parallel disease progression, were found in peripheral blood mononuclear cells (PBMCs) of sporadic ALS patients (Filareti et al., 2017; Nardo et al., 2011) . Accordingly, a progressive TDP-43 raise was also observed in PBMCs of hSOD1 G93A Tg swine before the onset of the symptomatic phase. All together these findings suggest that the hSOD1 G93A Tg pigs represent a remarkable ALS model and may strongly contribute to further support clinical research of ALS.
A C C E P T E D M A N U S C R I P T MATERIALS AND METHODS

Animals and breeding.
All procedures were conducted as described by the institutional guidelines that are in accordance with national (D.L. no. 116, G.U. suppl. 40, February 18, 1992 (D.L. no. 116, G.U. suppl. 40, February 18, , no. 8, G.U., 14 luglio 1994 D.L.26/2014) and international laws and policies (EEC Council Directive 86/609, 63/2010 , OJ L 358, December 12, 1987 ; National Institutes of Health Guide for the Care and Use of Laboratory Animals, US National Research Council, 1996) . hSOD1 G93A Tg pigs were produced as previously reported (Chieppa et al., 2014) . Among the four Tg cloned founder pigs (168, 174, 204, 205 ) that reached adulthood, Tg 168 was bred to establish a transgenic line and Tg 168 progeny was further investigated. The specific number of animals or samples used was stated in the figure captions. All experiments were designed to minimize the number of animals used and their discomfort (project authorization n 1043/2016-PR from Ministry of Health).
qPCR.
To determine the transgene copy number the 2 -ΔΔct method was applied, using genomic human DNA as a calibrator. The qPCR was performed using the iTaq Universal Sybr Green Supermix (Bio-Rad) and the following primers pair: SOD1Fw (5'-catgaacatggaatccatgcagg-3') and SOD1Rw (5'-taatggaccagtgaaggtgtg-3') for the human SOD1 gene and gapdhFW (5'-tgccacccagaagactgtgg-3') and gapdhRW (5'-accttgcccacagccttggc-3') for the glyceraldehyde-3-phosphate dehydrogenase as housekeeping gene. The program set on a Mx3000P thermocycler (Stratagene) consists of forty cycles composed of a denaturation step at 95°C for 10 sec followed by an annealing/extension step at 62°C for 30 sec. Data were presented as delta cycle threshold (ΔCt) between the SOD1 and housekeeping gene. The ΔCt values in Tg pigs and calibrator DNA were converted to relative transgene copy number by the equation 2 -ΔΔCt .
RT-PCR To determine MCP-1 mRNA levels total RNA was extracted from cervical spinal cord using the Trizol method (Invitrogen) and purified with PureLink RNA columns (Thermo Fisher Scientific). Real-time PCR was performed using the Taq Man Gene expression assay (Applied
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A C C E P T E D M A N U S C R I P T Biosystems) following the manufacturer's instructions, on 50 ng of cDNA specimens in triplicate, using 1X Universal PCR master mix (Thermo Fisher Scientific) and 1X mix containing the specific porcine probe for MCP1 (Ss03394377_m1; Thermo Fisher Scientific). Relative quantification was calculated from the ratio between the cycle number (Ct) at which the signal crossed a threshold set within the logarithmic phase of MCP1 gene and that of the reference β-actin gene (Ss03376081_u1;
Thermo Fisher Scientific). Mean values of the triplicate results for each animal were used as individual data for 2-ΔΔCt analysis.
Fluorescent In Situ Hybridization (FISH)
. FISH experiments were carried out as previously described on interphase and metaphase cells from three Tg founder pigs (168, 174, 204) (Paulis et al., 2015) . Tg 205 was not analyzed since it was a Tg 204-clone. Briefly, cell cultures were treated with KaryoMAX colcemid (Thermo Fisher Scientific) at a final concentration of 0.1 µg/ml for 2 hours at 37°C and cells were then detached by treatment with 0.25% trypsin/EDTA (Lonza). After hypotonic treatment with 0.075 M KCl and fixation in methanol: acetic acid (3:1 v/v), the cell suspension was dropped onto a slide and air dried. Slides were treated with 0.004% Pepsin (Sigma Aldrich) at 37°C for 10 sec and dehydrated through the ethanol series before denaturation in 70%
formamide/2xSSC. The hSOD1 G93A DNA vector was used as DNA probe. The DNA was labeled via nick translation (Enzo Life Sciences), using Bio-11-dUTP (Roche Diagnostics) and resuspended in hybridization buffer (50% formamide, 10% dextran sulphate, 1x Denhart's solution, 0.1% SDS, 40 mM Na2HPO4 pH 6.8, 2xSSC) containing 10x Salmon Sperm DNA. Before hybridization the probes were denatured at 80°C for 10 min and pre-annealed at 37°C for 20 min. Hybridization was carried out overnight at 37°C. Stringent washings were performed in 50% formamide/2xSSC at 42°C. For biotin detection, the slides were incubated with FITC-conjugated avidin DCS (Vector Laboratories), then with biotin-conjugated anti avidin D antibody (Vector Laboratories) and finally with FITC-conjugated avidin DCS. Avidin and all the antibodies were used at a final concentration of 5 µg/ml. Slides were mounted in Vectashield mounting medium with DAPI (Vector
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Splinkerette assay. The splinkerette ligation-mediated PCR was applied, as described in (Potter and Luo, 2010) . Briefly, the oligonucleotides SPLNK-BOT2 (5'-cga agagtaaccgttgctaggagagaccgtggctgaatgagactggtgtcgacactagtgg -3') and SPLNK-AATT-ApoI (5'-aattccactagtgtcgacaccagtctctaattttttttttcaaaaaaa-3') were annealed to generate the ApoI splinkerette linker. In parallel, genomic DNA (gDNA) of the Tg 168 founder was purified with standard procedure based on sodium dodecyl sulphate lysis supplemented with proteinase K followed by rounds of phenol and chloroform extractions. Purified gDNA was then ApoI digested and an aliquot (about 200 ng) was ligated with a 10-fold molar excess ApoI-splinkerette linker in a volume of about 50 µl. Ligated DNA was then amplified by three rounds of nested-PCR with v3-F1 (5'-cattaattgcgttgcgctcactgc-3'), v3-F2 (5'-ggtttgcgtattgggcgctcttc-3') and v3-F2 (5'-ggtttgcgtattgggcgctcttc-3') outward primers targeting the 3' end of the integrated vector and the SPL-S1 (5'-cgaagagtaaccgttgctaggagagacc-3') and SPL-S2 (5'-gtggctgaatgagactggtgtcgac-3') primers targeting the ApoI-splinkerette linker. The chimeric plasmidic-genomic amplified DNA was then sequenced by standard procedure. Next, undigested Tg 168 gDNA template was amplified with the v3-F1, v3-F2 and v3-F3 outward primers together with the g3-R1 (5'-ctccagtctcttacttcacccaactc-3'), g3-R2 (5'-gcatcttcttagtctcagagcctcaaacc-3') and g3-R3
(5'gataaatgttctcctgcacctattaatg-3') to prove that the vector is indeed contiguous with the isolated 3' flanking sequence. The primers targeting the 3'-flanking sequence gDNA, were also coupled with the g5-F1 (5'-ggaattaggagggtttggaaatagaactc-3'), g5-F2 (5'-
A C C E P T E D M A N U S C R I P T ggatagtcagcacatgcaacactgcattc-3') and g5-F3 (5'-gaggatcactggtttaatagggtgtagag-3') primers targeting the 5' flanking sequence of the genomic breakpoint to demonstrate that only one sister chromosome 2 was targeted by the tandem integration of the vectors into the Tg 168 genome. interpolating data points over a time base of 1000 points for each gait cycle (Courtine et al., 2005) and by fitting the data with a cubic spline to (Thorup et al., 2008) . Eventually, the obtained profiles of sEMG activity during the normalized gait cycle were averaged for each muscle.
Neurological examination
Histology and immunohistochemistry. Pigs were sacrificed according to the approved protocol of animal welfare. Brain and spinal cord were rapidly dissected out and formalin immersion-fixed for histology/immunohistochemistry or 4% PFA immersion-fixed for immunofluorescence analysis.
Tissues were then paraffin embedded or crioprotected in 30% sucrose and OCT embedded, 
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Neuromuscular junction analysis (NMJs). Gastrocnemius and peroneus muscles were
immersion-fixed in 4% PFA for 48 hours, cryoprotected in 30% sucrose and sectioned at 40 µm thickness on a freezing microtome. NMJs were visualized using Alexa 555-conjugated α-bungarotoxin (BTX, 1: 1000, Thermo Fisher Scientific) to label post-synaptic acetylcholine receptors and Neurofilament (1: 50, Novocastra, NCL-l-NF200-N52) to bind MN axons. Endplates were considered innervated if there was a complete overlay with the axon or denervated if the endplate was not occupied by MN terminal axons. In case of partial overlap, the NMJs were considered as partially innervated. At least 100 randomly selected endplates per muscle were analyzed using an epifluorescence microscope (Nikon).
Electron microscopy. Tg and control (CTR) lumbar spinal cord segments, gastrocnemius muscle
and sciatic nerve specimens were fixed by immersion in a solution containing 2.5% glutaraldehyde and 0.5% sucrose in 0.1 M Sorensen phosphate buffer, until embedding. Samples were then postfixed in 1% osmium tetroxide and dehydrated in ascending series of ethanol (from 30% to 100%).
After two brief passages in propylene oxide and o/n in a mixture of propylene oxide and Glauerts mixture of resins, specimens were embedded in Glauerts mixture of resins (50:50 Araldite M and Araldite Harter, HY 964): in the resin mixture, 0.5% of the plasticizer dibutylphthalate was added, followed by 2% of accelerator 964, used to promote the polymerization of the embedding mixture.
Semi-thin (1-μm thick) sections were then cut, using a Ultracut UCT ultramicrotome (Leica Microsystems) and stained by 1% Toluidine blue for light microscopy examination and morphological analysis. For transmission electron microscopy (TEM), ultra-thin sections (80-nm thick) were cut using the Ultracut UCT ultramicrotome, and counterstained with Uranyl Acetate
Replacement Stain (Electron Microscopy Sciences). Ultra-thin sections were observed by a JEM-
e. ratio of the inner axonal diameter to the total outer diameter), toluidine blue stained sections of Tg and CTR sciatic nerve were analyzed: approximately 150 axons have been evaluated for each group. Fiber (i.e. axon and myelin) and axon diameters have been measured by Neurolucida software (MicroBrightField), using the "quick measure line" tool.
Western blotting. Protein extracts were prepared from central nervous system -CNS-(spinal cord, brainstem, cerebellum, cortex and striatum) and muscles homogenates. Depending on the experimental reasons to be achieved, different extraction protocols have been used. We analyzed either soluble and/or triton insoluble fractions (TIF) according to (Ouyang and Hu, 2001 ).
Western blotting was performed using SDS polyacrylamide gels (NuPAGE 4-12% Bis-Tris gel or 
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TDP-43 pathology by biochemical approaches
To evaluate TDP-43 aggregation, TIF was isolated from frontal cortex and spinal cord tissues of Tg and control pigs and analyzed by dot blot, as described (Basso et al., 2009 ).
To evaluate TDP-43 mislocalization in cervical spinal cord of the Tg 168 pig, TDP-43 level was measured in the nuclear and cytoplasmic fractions in comparison with a control animal (CTR1).
Subcellular fractionation of the tissue was done as previously described (Lauranzano et al., 2015; Pasetto et al., 2017) . Mouse monoclonal anti-GAPDH (1:10.000 dilution; Millipore) and mouse monoclonal anti-lamin A/C (1:500 dilution; Chemicon) were used, respectively, as cytoplasmic and nuclear markers. Level of TDP-43 in nuclear and cytoplasmic fractions was analyzed by dot blot.
Dot blot analysis.
Protein lysates (3 µg) from PBMC, nuclear and cytoplasmic fractions and TIF were directly loaded onto nitrocellulose Trans-Blot transfer membranes (Bio-Rad) by vacuum filtration, as described previously (Nardo et al., 2011 ). An internal standard which is a pool of all samples in the analysis was deposited in triplicates. Dot blot membranes were blocked with 3%
(w/v) BSA (Sigma Aldrich) and 0.1% (v/v) Tween 20 in Tris-buffered saline, pH 7.5, incubated with rabbit polyclonal anti-TDP-43 primary antibody (1:2500 dilution; Proteintech), then with antirabbit peroxidase-conjugated secondary antibody (1:5000 for IB; Santa Cruz Biotechnology Inc.).
Blots were developed with Luminata TM Forte Western Chemiluminescent HRP Substrate (Millipore) on the ChemiDoc XRS system (Bio-Rad). Densitometry was done with Progenesis PG240 v2006 software (Nonlinear Dynamics). The immunoreactivity of the different proteins was normalized to Ponceau Red staining (Fluka) and to the internal standard of each membrane. Whitney U test for 3DMC, an unpaired t test for LC3-positive puncta count, g-ratio, fiber size and myelin thickness measurements, a chi square test for fiber size distribution analysis anda one-way ANOVA with Tukey's multiple comparisons test for TDP-43 levels, as specified in the figure legends. P < 0.05 was considered significant.
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A C C E P T E D M A N U S C R I P T RESULTS
Molecular analysis of cloned hSOD1 G93A Tg pigs
Transgenic cloned founder pigs expressing the human pathological allele hSOD1 G93A were previously generated by SCNT of primary porcine fibroblasts and the transgene integration pattern of the ApaL1 linearized pMG5 ′ 3 ′ MARPuro-hSOD1 G93A plasmid vector analyzed by Southern blot (Chieppa et al., 2014) . Here, cytogenetic mapping was carried out by fluorescent in situ Figure 3b ). Electron microscopy images also revealed evident nuclear alterations, characterized by presence of nucleolar cavities and electron dense granules in Tg pig with respect to CTR pig (Figures 3c, d) . Moreover, immunostaining examination of MN Golgi apparatus (GA), revealed fragmentation and reduced GA content in Tg compared to CTR pigs (Figures 3e, f) .
Quantification of CV-stained spinal cord MNs revealed a statistically significant decrease of MN counts at cervical and thoracic (C1-C2, T6-T8, T9-T11) levels in Tg pigs (Figure 3g ). Average differences of MN counts in Tg pigs compared with CTR group were 52% in C1-C2 (P = 0.004; 95% CI 17-88%), 43% in T6-T8 (P = 0.017; 95% CI 8-80%) and 42% in T9-T11 (P = 0.037; 95% CI 2.4-81%). A neuroinflammatory response was observed; in end stage Tg pigs lumbar spinal cord, Iba1 and GFAP immunostaining were prominently increased compared to CTR (Figures 3h-k ). Immunoblot analysis confirmed that Iba1 amounts were significantly higher in Tg pigs (+112%, P < 0.001 95% CI 79-115%). Microgliosis was uniformly distributed in spinal cord, indeed no difference in protein amounts were found, considering the spinal cord level (cervical, thoracic or lumbar; P = 0.871 in thoracic and P = 0.233 in lumbar vs cervical spinal cord;) in Tg pigs ( Figure   3l ). Estimates of the mean percentage differences of GFAP expression between Tg and CTR group was 94% (P = 0.01, 95% CI 22-165%) with a statistically significant increase of astrocytosis from cervical to lumbar trait in Tg compared to CTR pigs (53%, P = 0.01, 95% CI 13-159% in thoracic trait and 66%, P = 0.02, 95% CI 25-107% in the lumbar trait; Figure 3m ). In line with the activated gliosis, quantitative polymerase chain reaction analysis revealed that the proinflammatory MCP-1 mRNA levels were higher in Tg (Tg 168 and its F1 progeny, Tg 305) than those in CTR pigs ( Figure S2 ).
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Additionally, H&E analysis of brainstem nuclei revealed vacuolization of the neurons and neuropil (Figures 3n, o 
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and rare fiber splitting were also visible (Figures 4e-j (Figures 4e-h ). Moreover, a normal distribution of glycogen was observed by PAS staining (data not shown). ATPase activity indicated that both fiber types were involved by lesions, particularly type II fibers (Figures 4i, j) . By contrast, the cytoarchitecture of extraocular muscles was well preserved, as reported for human patients (data not shown). Semi-thin sections analysis from gastrocnemius muscle showed unparalleled and disarranged muscle fibers in affected Tg pigs (Figure 4l ), whereas longitudinal, regular and aligned muscle fibers with the expected typical banding pattern were detected in parallel sections of CTR pigs (Figure 4k ).
Neuromuscular junction denervation and neuropathy are evident in hSOD1 G93A Tg pigs
Immunofluorescence analysis of α-bungarotoxin (BTX) and neurofilament was performed and the innervation of motor endplates in gastrocnemius and peroneus muscles was scored as innervated, partially innervated or denervated (Figures 5a-c) . End stage Tg pigs showed consistent denervation of the NMJs in the gastrocnemius (24.9%) and peroneus (25.5%) muscles compared to 6.2% and 13.7% in CTR pigs (Figure 5d ). In particular, linear mixed model adjusted for muscle tissue showed a significant increase of the mean denervation percentage (15.64%, P < 0.0001, 95% CI 7-24.25%), in gastrocnemius (18.64%, P = 0.01, 95% CI 4.47 -32.82%) and peroneus (11.83%; P < 0.0001, 95% CI 6.88-16.77%) muscles in Tg compared to CTR group. No differences were observed between Tg and CTR pigs in the percentage of partially innervated NMJs (P = 0.528, 95%
CI 10.88-21.22%).
The morphology analysis of sciatic nerves showed uniform and compact axonal fibers in CTR pig, whereas Tg nerve exhibited differently-sized and smaller fibers, immersed in more abundant endoneurial tissue (Figures 5e, f) . The g-ratio was significantly different between CTR and Tg animals (CTR 0.498 ± 0.014 µm vs Tg 0.570 ± 0 .014 µm; P = 0.005; Figure 5g ). Such results highlight an overall reduction in the Tg fiber size (CTR 13.3 ± 0.5 µm vs Tg 8.9 ± 0.6 µm; P =
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0.0016), particularly affecting myelin thickness (CTR 6.5 ± 0.2 µm vs Tg 3.8 ± 0.3µm; P = 0.0005).
Moreover, the fiber size distribution revealed a remarkable shift to lower size in Tg vs CTR pigs, also underlining only in the Tg group the presence of a peak at 4-5 µm (P ≤ 0.001) as a plausible sign of an occurring neuropathy (Figure 5h ) (Riva et al., 2014) . Figures S5 a-f) . Surprisingly, a prominent staining of hSOD1 in skeletal muscles was found (Figures 6g, h ). hSOD1 deposition was observed in the cytoplasm of myofibers with a scattered distribution, mainly as amorphous aggregates (Figure 6h ). By means of the SEDI antibody, the presence of misfolded hSOD1whithin these muscle aggregates was confirmed (Figures 6i, j) .
Next, SOD1 protein in the triton-insoluble fraction (TIF) as compared with the soluble fraction from both Tg versus CTR pigs, was quantified as an index of protein aggregate accumulation in different CNS areas. Notably, the amounts of the mutant hSOD1 protein were comparable to that of the endogenous swine protein (sSOD1) (linear mixed-model, P = 0.967) and did not vary significantly among several CNS samples (cortex, cerebellum, striatum, brainstem and spinal cord; linear mixed-model, P > 0.1), both in the soluble and insoluble fractions (Figure 6k ). In addition, no
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TDP-43 levels in PBMCs as a potential biomarker for disease onset
The increase of the TDP-43 protein level in PBMCs parallels the disease progression in ALS patients (Nardo et al., 2011) . Therefore this biomarker was investigated in symptomatic, asymptomatic hSOD1 G93A Tg pigs and also in CTR pigs. TDP-43 levels were low and comparable between CTR and Tg pigs that did not develop the disease (Tg 174, 204, 205) . In PBMC samples of presymptomatic pigs (Tg 409, Tg 411 and Tg 168), TDP-43 levels were significantly higher than CTR pigs (P < 0.05). In particular, in PBMC samples of Tg 168 pig, the TDP-43 began to raise during the very early presymptomatic stage (from 22 to 25 months of age), doubled its level at 25 months of age compared with the asymptomatic and CTR samples, and reached the highest level when the disease was at the end stage (P < 0,05 versus CTR, asympptomatic and presymptomstic pigs). In conclusion, the TDP-43 levels raised at least two months before the onset of the clinical symptoms, opening the possibility to employ this biomarker to monitor the ALS families even at presymptomatic stage (Figure 7 ). In addition, to further characterize TDP-43 pathology in the Tg swine model, insoluble TDP-43 in spinal cord and frontal cortex tissues of Tg pigs (Tg 168, 305, 307) and CTRs, was measured. As shown in Figure S6 a, b , the level of TDP-43 in the TIF fraction was higher in Tg than in CTR pigs, although t test was not significant (P= 0.1 for spinal cord and P= 0.07 for frontal cortex). Interestingly, increased levels of insoluble TDP-43 with the same method were found also in G93ASOD1 mouse models of ALS (Lauranzano et al., 2015; Marino et al., 2015) . Moreover, in cervical spinal cord the levels of nuclear and cytoplasmic TDP-43 were respectively lower and higher in Tg 168 than CTR pig ( Figure S7 a, b) , indicative of a cytoplasmic mislocalization of TDP-43, similarly to the G93ASOD1 mouse model (Lauranzano et al., 2015) .
Consistently, weaker nuclear TDP-43 staining of large neurons was found in Tg 168 compared to ACCEPTED MANUSCRIPT
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CTR pig, even if no TDP-43-positive cytoplasmic inclusions were apparent ( Figure S7 c, d ).
Nevertheless, the affected SMI-31-positive MN in Tg pigs were TDP 43 and phospho TDP-43 positive as observed in serial sections ( Figure S7 e-g ).
DISCUSSION
In this study, a swine model of familial ALS disease is described. The expression of the human pathological allele of SOD1 gene with the G93A mutation caused an ALS like-disease in pigs with an autosomal mendelian trait. As in humans, the onset of the ALS disease occurs after a quite long asymptomatic period (about 27 months) with full penetrance in the progeny of affected transgenic Tg 168 founder developed a neuromuscular disease characterized by progressive paresis, MN degeneration and gliosis. Cytogenetic and molecular analysis revealed that the transgenic vector was integrated in multiple (about 20 copies) tandem-repeat copies in a single site of the host swine genome on chromosome 2q24. High resolution mapping allowed to map the chromosome breakpoint at chr2: bp124045533 quite far (about 655 kb and 288 kb at the 5' and 3' end of the breakpoint, respectively) from known coding genes, supporting the evidence that no coding genes were interrupted by the integration event. This is also evident from the genotype analysis of the Tg
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A threshold level of pathological hSOD1 G93A seems to be required to trigger the disease by a gain of function mechanisms, however immunoblot analysis showed comparable amounts between transgenic and endogenous SOD1 proteins, which may reasonable exclude any putative aspecific toxic or artificial effect due to overexpression of the transgenic protein, such as squelching, on causing the clinical symptoms. Another transgenic SOD1 G93A pig model was reported by Yang et al. (Yang et al., 2014) showing hSOD1 expression level lower than or equivalent to the endogenous one; however, in these pigs limb movement defects started as early as 3 months of age. This discrepancy could be dependent on several factors widely explored in SOD1 mice (i.e. gender, genetic background); moreover, no transgene integration data were reported for this model.
From a clinical point of view, Tg pigs showed a long pre-symptomatic phase lasting about two years followed by the development of gait abnormality starting on hind limbs and which progressively worsened with concomitant dysphagia and severe respiratory impairment, till the humane end point was reached, after approximately four months. Similarly, in humans, the mutant G93A SOD1 is associated to a rapid disease progression and more severe neurological symptoms which last 1 to, at most, 4 years (Kato, 2008) ; moreover, SOD1 patients present mostly with limb onset, starting predominantly in lower limb rather than upper limb. Those cases with worse prognosis present also with bulbar onset with dysarthria, dysphagia and earlier respiratory dysfunction due to involvement of the cervical phrenic MNs (Chen et al., 2013; Swinnen and Robberecht, 2014) underlying that the clinical phenotype in Tg pigs resembled that of ALS patients.
In order to both test muscle activity during gait in awake pigs and to reduce the invasiveness of the procedure, electrophysiological analysis by sEMG instead of needle EMG, was performed. A clear pattern of spastic co-contraction of the gastrocnemius and peroneus muscle in Tg 168 at the end stage but not in control pigs or other asymptomatic Tg pigs was observed. Spasticity is reported in
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patients as a sign of upper motor neuron involvement; here, the motor cortex role is under investigation.
At disease end-stage, Tg pigs developed key neuropathological features of ALS including MNs degeneration and loss, gliosis and the presence of SOD1 positive inclusions. In particular, the number of surviving MNs was decreased in Tg pigs compared to control pigs in some areas of the spinal cord, confirming the focal spread of the disease as observed in patients (Ravits and La Spada, 2009 ), whereas activated astrocytes and microglia were increased in association with an increase of the proinflammatory chemokine MCP-1 which has been demonstrated to correlate with the disease progression in ALS patient and mouse model (Guo et al., 2017; Kawaguchi-Niida et al., 2013) .
Additionally, Tg pig showed shrunken and atrophied neuronal cell bodies with nucleolar alterations.
Similar abnormalities were reported as a sign of degeneration preceding neuronal death (Kiernan and Hudson, 1993) and analogous nucleolar enlargement have been described in a murine model of Pukinje cell degeneration (Baltanas et al., 2011) . Moreover, although vacuolization pathology is not a common feature in postmortem tissues of both sporadic ALS (SALS) and familial (FALS) patients at the end stage (Higgins et al., 2003) , SOD1 mice exhibit abundant vacuoles in neurons and neuropil at the presymptomatic stage of disease which become less evident at the end stage (Bendotti et al., 2012; Sumi et al., 2006) . Thus, the mild vacuolization pathology observed in the brainstem of Tg pigs may represent an early stage in the process of neurodegeneration. Another interesting result obtained in Tg pigs is the presence of MNs Cleaved Caspase 3, a final effector of apoptotic cell death, but none TUNEL-positive cells. Even if there is compelling evidence indicating that MN death in ALS patients and SOD1 G93A mice does not occur through apoptosis (He and Strong, 2000; Migheli et al., 1999) , a toxic cascade characterized by the sequential activation of Caspase 1 and Caspase 3 has been implicated in the vulnerability of MNs in ALS (Pasinelli et al., 2000) . Our results in Tg pigs confirm previous findings in ALS mice, suggesting that caspase activation is a feature of neurodegenerative processes associated to mutant SOD1 but MN death do not occur through apoptosis. The evaluation of the autophagy pathway revealed a huge increase in
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A C C E P T E D M A N U S C R I P T the number of LC3-positive vesicles in Tg ventral horn MNs suggesting a likely dysfunction of the autophagic system in Tg swine model; a similar upregulation of autophagic markers has been already reported in several ALS murine models and in human patients (Nguyen et al., 2018; Song et al., 2012) . Tg pigs showed loss of the normal network of elements of the Golgi Apparatus (GA), which appeared dispersed and isolated in most of the remaining spinal MNs. The fragmentation of the GA was frequently observed in patients with sporadic, familial and juvenile ALS and in
SOD1
G93A Tg mice appears long before the onset of disease suggesting that it is an early sign of neuronal degeneration (Fujita and Okamoto, 2005) . Moreover, it was suggested that GA fragmentation could be related to the presence of protein aggregates which were detected in our Tg pigs, contrary to that was previously reported in a similar hSOD1 pig model (Yang et al., 2014) .
Protein aggregates represent a hallmark of ALS in humans, appearing as intracytoplasmic eosinophilic inclusions (Bunina bodies) or as round ialine and skein like inclusions (Blokhuis et al., 2013) . In brainstem neurons and neuropil of our Tg pigs we found both round and skein-like inclusions which were immunopositive for hSOD1 and most importantly, for the misfolded form of SOD1. Therefore, altogether these data suggest the validity of Tg pigs as a useful model to study certain etiopathogenetic aspects (e.g. protein misfolding and aggregation) in ALS.
Particularly striking in our Tg pig model is the muscular pathology characterized by necrosis and inflammation associated to a massive deposition of the human SOD1 protein, NMJ denervation and distal axonopathy. Acute or chronic neurogenic atrophy and mitochondria dysfunction are common findings in muscle biopsies of FALS and SALS patients and similarly Tg SOD1 mice. Our results in Tg pigs at the end stage revealed a pattern resembling a muscular dystrophy rather than a mere denervation atrophy with the presence of several degrees of inflammation, necrosis and fibrosis.
This severe muscular pathology could be due to the elevated expression of mutant SOD1 in skeletal muscles of our Tg pigs. Wong et al. (Wong and Martin, 2010) demonstrated that hSOD1 toxicity to skeletal muscles involves oxidative damage and nitrative stress but it is independent of the formation of SOD1 aggregates. Nevertheless, the role of mutant SOD1 aggregates in impairing ACCEPTED MANUSCRIPT
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protein conformation and the consequent muscle loss in ALS remains elusive (Wei et al., 2012) . To our knowledge, there are no reports regarding SOD1 aggregation in ALS patient muscles, however, the presence of dystrophic-like changes in Tg pigs suggests that mutant SOD1 might contributes to muscle degeneration. Substantial evidence indicates that the pathological process leading to ALS involves multiple cell types, including skeletal muscle cells. In particular, different studies demonstrated in both ALS patients and animal models, defects in the skeletal muscle that occur even in the absence of motor neuron death, supporting the "dying-back" hypothesis in which distal motor endplate degeneration plays a key role in the progression of the disease (Dupuis and Loeffler, 2009; Fischer et al., 2004; Musaro, 2013; Rocha et al., 2013) . Selective expression of mutant SOD1
in mouse skeletal muscles under the transcriptional control of muscle-specific promoter (MLC)
induced progressive muscle atrophy, reduction in muscle strength and mitochondrial dysfunction without MN degeneration (Dobrowolny et al., 2008) . On the contrary, another study reported that the expression of mutant SOD1 in skeletal muscles causes MN degeneration as a later event after muscle pathology (Wong and Martin, 2010) . Thus, although initially the "neurocentric" dogma assumed that MN degeneration, caused by mutant SOD1, was the main driver of muscular atrophy, more recent evidence suggests that muscular dysfunction could precede and contribute in triggering MN degeneration (Fischer et al., 2004; Frey et al., 2000; Moloney et al., 2014) . Consistently, we found that Tg pigs displayed marked signs of distal axonopathy and denervation in the gastrocnemius and peroneus muscles despite of the lack of a significant loss of MNs in the lumbar spinal cord. Further studies involving animals at different stage of disease (e.g. early, mid and late symptomatic) are requested.
Notably, we have also found that Tg pigs that develop the disease has a higher total TDP-43 protein level in PBMCs than CTR and asymptomatic Tg controls, similarly to ALS patients (Filareti et al., 2017; Nardo et al., 2011) thus confirming the robustness of the pathological phenotype of this animal model. Moreover, we demonstrated that total TDP-43 protein level is an early disease biomarker, since it underscores disease also before overt clinical symptoms, an aspect that could not
ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T be explored in the patients. Interestingly, in this respect the Tg pig model is more similar to the patients than to the SOD1 G93A mouse model in which we could not find higher TDP-43 levels in PBMCs compared to CTRs (Filareti et al., 2017 ).
In conclusion, altogether our data demonstrated that Tg pigs might represent a similar and representative model of human ALS and thus offer several advantages compared to rodents such as the possibility to study the etiopathogenetic events that precede the onset of disease and potential diagnostic and prognostic biomarkers. Furthermore, the longer symptomatic phase and the large size might allow to test for novel drugs and possible advanced therapy medicinal products.
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